(Q73398082)

English

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

scientific article published on 01 December 1999

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

based on heuristic

inferred from title

author name string

M Aubier

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W R Pieters

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

N J Schlösser

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K O Steinmetz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Respiratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

876-884

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2899%2990053-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0954-6111(99)90053-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10653049%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73398082&oldid=1832272676"